solid tumor

A series of dice with a bag on them illustrating cost cuts
Biotech

Turnstone lays off 60%, shakes up C-suite to stretch out cash

Turnstone Biologics is reducing its headcount by 60% and shaking up its C-suite in order to keep the cash flowing to its sole clinical-stage candidate.
James Waldron Oct 11, 2024 8:05am
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Ono inks $700M biobuck deal to bag preclinical LigaChem ADC

Oct 10, 2024 9:40am
3d rendering of a semi-opened steel safe box with many paper dollar banknotes flying out of it

Context builds bispecific bank with $133M biobucks deal

Sep 23, 2024 11:20am
cancel

ESMO: Bristol Myers axes Immatics' bispecific after $150M bet

Sep 16, 2024 6:59am
start line beginning road path starting point journey

ESMO: AstraZeneca posts data on ADC rivals to AbbVie, Pfizer

Sep 14, 2024 3:00am
gas burners cooking

ESMO: Regeneron's Opdualag rival shows 57% response rate

Sep 14, 2024 3:00am